Understand the source comparison
Best Peptides for REM Sleep Research: Sleep Architecture Comparison
Before selecting a peptide for REM-focused research, understanding how each compound alters specific sleep stages is essential. The table below compares DSIP, Epitalon, and GHRP-2 across mechanism, targeted sleep phase, administration timing, and measurable po
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a peptide for REM-focused research, understanding how each compound alters specific sleep stages is essential. The table below compares DSIP, Epitalon, and GHRP-2 across mechanism, targeted sleep phase, administration timing, and measurable polysomnographic outcomes.
- DSIP (Delta Sleep-Inducing Peptide)
- Cortisol antagonism; increases delta-wave amplitude in SWS
- Slow-wave sleep (SWS) preceding REM
- 22:00–01:00 (cortisol nadir)
- Indirect: deeper SWS extends subsequent REM rebound by 18–24%
- Best for studies targeting SWS-to-REM transitions; requires strict circadian timing
- Epitalon (Ala-Glu-Asp-Gly)
- Upregulates pineal NAT enzyme; increases melatonin synthesis
- REM onset and duration
- 19:00–20:00 (pre-melatonin synthesis window)
- Direct: reduces REM latency by 12–18 min; increases REM percentage by 2.8–4.1%
- Ideal for REM fragmentation studies; effect scales with baseline melatonin deficiency
- GHRP-2 (Growth Hormone-Releasing Peptide 2)
- Stimulates pituitary GH release during first SWS cycle
- SWS depth (indirect REM modulation)
- 22:00–22:45 (30–45 min before sleep onset)
- Indirect: 4.2-fold GH increase correlates with 4.8% rise in REM percentage
- Strongest effect in populations with blunted GH secretion; less effective in young adults